The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis

Schizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known to contribute to the disease pathology. One potential contributor is the family of neurotrophins which are proteins involved in multiple funct...

Full description

Saved in:
Bibliographic Details
Published inJournal of psychiatric research Vol. 106; pp. 43 - 53
Main Authors Rodrigues-Amorim, Daniela, Rivera-Baltanás, Tania, Bessa, João, Sousa, Nuno, Vallejo-Curto, María de Carmen, Rodríguez-Jamardo, Cynthia, de las Heras, María Elena, Díaz, Roberto, Agís-Balboa, Roberto Carlos, Olivares, J.M., Spuch, Carlos
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2018
Online AccessGet full text

Cover

Abstract Schizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known to contribute to the disease pathology. One potential contributor is the family of neurotrophins which are proteins involved in multiple functional processes in the nervous system, with crucial roles in neurodevelopment, synaptogenesis and neuroplasticity. With these roles in mind, abnormal neurotrophin profiles have been hypothesized to contribute to the pathology of schizophrenia. We performed a systematic review and a meta-analysis to scrutinize the neurobiological hypothesis of neurotrophins in schizophrenia, examining the correlation between peripheral levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3) and neurotrophin 4/5 (NT-4/5) associated with schizophrenia. Fifty-two studies were reviewed and twenty-two studies were included in this meta-analysis. Using a random effects model, we confirmed that decreased levels of neurotrophins (BDNF, NGF and NT-4/5) were associated with schizophrenia (Hedges's g = −0.846; SE = 0.058; 95% confidence interval: −0.960 to −0.733; Z-value = −14.632; p-value = 0.000). Subgroup analysis indicated that neurotrophin levels are significantly decreased in both medicated and drug-näive patients. Meta-regression of continuous variables such as mean age, duration of illness and PANSS total score did not show significant effects (p > 0.05) in relation to neurotrophins levels. We confirm that decreased peripheral neurotrophin levels are significantly associated with schizophrenia, thereby confirming the neurobiological hypothesis of neurotrophins in schizophrenia. Low levels of neurotrophins in peripheral blood of patients with schizophrenia may explain, in part, the pathophysiology of schizophrenia. •Neurotrophins are associated with the pathophysiology of schizophrenia.•Patients with schizophrenia have decreased levels of neurotrophins.•Peripheral levels of neurotrophins contribute to the neurobiological hypothesis of schizophrenia.
AbstractList BACKGROUNDSchizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known to contribute to the disease pathology. One potential contributor is the family of neurotrophins which are proteins involved in multiple functional processes in the nervous system, with crucial roles in neurodevelopment, synaptogenesis and neuroplasticity. With these roles in mind, abnormal neurotrophin profiles have been hypothesized to contribute to the pathology of schizophrenia. METHODSWe performed a systematic review and a meta-analysis to scrutinize the neurobiological hypothesis of neurotrophins in schizophrenia, examining the correlation between peripheral levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3) and neurotrophin 4/5 (NT-4/5) associated with schizophrenia. RESULTSFifty-two studies were reviewed and twenty-two studies were included in this meta-analysis. Using a random effects model, we confirmed that decreased levels of neurotrophins (BDNF, NGF and NT-4/5) were associated with schizophrenia (Hedges's g = -0.846; SE = 0.058; 95% confidence interval: -0.960 to -0.733; Z-value = -14.632; p-value = 0.000). Subgroup analysis indicated that neurotrophin levels are significantly decreased in both medicated and drug-näive patients. Meta-regression of continuous variables such as mean age, duration of illness and PANSS total score did not show significant effects (p > 0.05) in relation to neurotrophins levels. DISCUSSIONWe confirm that decreased peripheral neurotrophin levels are significantly associated with schizophrenia, thereby confirming the neurobiological hypothesis of neurotrophins in schizophrenia. Low levels of neurotrophins in peripheral blood of patients with schizophrenia may explain, in part, the pathophysiology of schizophrenia.
Schizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known to contribute to the disease pathology. One potential contributor is the family of neurotrophins which are proteins involved in multiple functional processes in the nervous system, with crucial roles in neurodevelopment, synaptogenesis and neuroplasticity. With these roles in mind, abnormal neurotrophin profiles have been hypothesized to contribute to the pathology of schizophrenia. We performed a systematic review and a meta-analysis to scrutinize the neurobiological hypothesis of neurotrophins in schizophrenia, examining the correlation between peripheral levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3) and neurotrophin 4/5 (NT-4/5) associated with schizophrenia. Fifty-two studies were reviewed and twenty-two studies were included in this meta-analysis. Using a random effects model, we confirmed that decreased levels of neurotrophins (BDNF, NGF and NT-4/5) were associated with schizophrenia (Hedges's g = -0.846; SE = 0.058; 95% confidence interval: -0.960 to -0.733; Z-value = -14.632; p-value = 0.000). Subgroup analysis indicated that neurotrophin levels are significantly decreased in both medicated and drug-näive patients. Meta-regression of continuous variables such as mean age, duration of illness and PANSS total score did not show significant effects (p > 0.05) in relation to neurotrophins levels. We confirm that decreased peripheral neurotrophin levels are significantly associated with schizophrenia, thereby confirming the neurobiological hypothesis of neurotrophins in schizophrenia. Low levels of neurotrophins in peripheral blood of patients with schizophrenia may explain, in part, the pathophysiology of schizophrenia.
Schizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known to contribute to the disease pathology. One potential contributor is the family of neurotrophins which are proteins involved in multiple functional processes in the nervous system, with crucial roles in neurodevelopment, synaptogenesis and neuroplasticity. With these roles in mind, abnormal neurotrophin profiles have been hypothesized to contribute to the pathology of schizophrenia. We performed a systematic review and a meta-analysis to scrutinize the neurobiological hypothesis of neurotrophins in schizophrenia, examining the correlation between peripheral levels of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3) and neurotrophin 4/5 (NT-4/5) associated with schizophrenia. Fifty-two studies were reviewed and twenty-two studies were included in this meta-analysis. Using a random effects model, we confirmed that decreased levels of neurotrophins (BDNF, NGF and NT-4/5) were associated with schizophrenia (Hedges's g = −0.846; SE = 0.058; 95% confidence interval: −0.960 to −0.733; Z-value = −14.632; p-value = 0.000). Subgroup analysis indicated that neurotrophin levels are significantly decreased in both medicated and drug-näive patients. Meta-regression of continuous variables such as mean age, duration of illness and PANSS total score did not show significant effects (p > 0.05) in relation to neurotrophins levels. We confirm that decreased peripheral neurotrophin levels are significantly associated with schizophrenia, thereby confirming the neurobiological hypothesis of neurotrophins in schizophrenia. Low levels of neurotrophins in peripheral blood of patients with schizophrenia may explain, in part, the pathophysiology of schizophrenia. •Neurotrophins are associated with the pathophysiology of schizophrenia.•Patients with schizophrenia have decreased levels of neurotrophins.•Peripheral levels of neurotrophins contribute to the neurobiological hypothesis of schizophrenia.
Author Vallejo-Curto, María de Carmen
Spuch, Carlos
Sousa, Nuno
Díaz, Roberto
Agís-Balboa, Roberto Carlos
Rodríguez-Jamardo, Cynthia
de las Heras, María Elena
Olivares, J.M.
Rodrigues-Amorim, Daniela
Rivera-Baltanás, Tania
Bessa, João
Author_xml – sequence: 1
  givenname: Daniela
  surname: Rodrigues-Amorim
  fullname: Rodrigues-Amorim, Daniela
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 2
  givenname: Tania
  orcidid: 0000-0002-3723-6039
  surname: Rivera-Baltanás
  fullname: Rivera-Baltanás, Tania
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 3
  givenname: João
  surname: Bessa
  fullname: Bessa, João
  organization: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
– sequence: 4
  givenname: Nuno
  surname: Sousa
  fullname: Sousa, Nuno
  organization: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
– sequence: 5
  givenname: María de Carmen
  surname: Vallejo-Curto
  fullname: Vallejo-Curto, María de Carmen
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 6
  givenname: Cynthia
  surname: Rodríguez-Jamardo
  fullname: Rodríguez-Jamardo, Cynthia
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 7
  givenname: María Elena
  orcidid: 0000-0003-0051-9964
  surname: de las Heras
  fullname: de las Heras, María Elena
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 8
  givenname: Roberto
  orcidid: 0000-0002-0114-2292
  surname: Díaz
  fullname: Díaz, Roberto
  organization: Hospital Universitari Institut Pere Mata, IISPV, URV, CIBERSAM, Reus, Spain
– sequence: 9
  givenname: Roberto Carlos
  orcidid: 0000-0001-9899-9569
  surname: Agís-Balboa
  fullname: Agís-Balboa, Roberto Carlos
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 10
  givenname: J.M.
  surname: Olivares
  fullname: Olivares, J.M.
  email: jose.manuel.olivares.diez@sergas.es
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
– sequence: 11
  givenname: Carlos
  surname: Spuch
  fullname: Spuch, Carlos
  email: carlos.spuch.calvar@sergas.es
  organization: Neuroscience Translational Group, Galicia Sur Health Research Institute, SERGAS-UVIGO, CIBERSAM, Spain
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30269004$$D View this record in MEDLINE/PubMed
BookMark eNqFkE1v1DAQhi1URLctfwH5yCXpjON8mFupCkWqxKWcLa8zIV5l7WBnkdJfj7fbwpGTpZnnnRk_F-zMB0-McYQSAZvrXbmb02pHFymVArArQZUA7Ru2wa5VBVatOmMbACGKStXNObtIaQeZECjfsfMKRKMA5IaNjyNxT4cYti5M4aezZuLjOodlpOQSD8Opu8Qwj84n7jzPLT6bZcyVNT2n1iOX8j1PuRbJO_OJ3_A9LaYw3kyZSlfs7WCmRO9f3kv248vd4-198fD967fbm4fCyqZeiqHpVDeoGmwlBouwBaGk6gDbBsUgt21jsFeqqkXbywotycoCEKKV0PZ1X12yj6e5cwy_DpQWvXfJ0jQZT-GQtEDMWdkhZrQ7oTaGlCINeo5ub-KqEfTRs97pf5710bMGpbPFHP3wsuWw3VP_N_gqNgOfTwDlv_52FHWyjrylPs-yi-6D-_-WP9Krl1I
CitedBy_id crossref_primary_10_1016_j_critrevonc_2022_103748
crossref_primary_10_1016_j_genrep_2023_101824
crossref_primary_10_12923_2353_8627_2023_0010
crossref_primary_10_3389_fcell_2022_1018586
crossref_primary_10_1016_j_comppsych_2019_152122
crossref_primary_10_1038_s41598_021_99510_7
crossref_primary_10_1016_j_psyneuen_2020_104879
crossref_primary_10_1016_j_phymed_2019_153012
crossref_primary_10_1016_j_jpsychires_2020_04_009
crossref_primary_10_1007_s40473_019_00178_1
crossref_primary_10_1016_j_psyneuen_2019_06_006
crossref_primary_10_1186_s12888_021_03578_4
crossref_primary_10_1016_j_bbi_2021_07_009
crossref_primary_10_1016_j_neuropharm_2019_04_001
crossref_primary_10_1038_s41537_022_00215_1
crossref_primary_10_1192_bjp_2020_259
crossref_primary_10_1002_mpr_1982
crossref_primary_10_1038_s41598_020_71060_4
crossref_primary_10_3390_jpm13091395
crossref_primary_10_3389_fendo_2023_1120127
crossref_primary_10_1016_j_psyneuen_2019_104473
crossref_primary_10_1016_j_scitotenv_2021_150014
crossref_primary_10_1111_pcn_13078
crossref_primary_10_3390_ijms22168499
crossref_primary_10_2174_1573400515666190719155906
crossref_primary_10_1007_s12403_023_00565_w
crossref_primary_10_1007_s11920_019_1063_7
crossref_primary_10_1016_j_psychres_2023_115402
crossref_primary_10_1016_j_euroneuro_2022_02_003
crossref_primary_10_1016_j_schres_2019_03_010
crossref_primary_10_3390_ijms24031891
crossref_primary_10_1016_j_pnpbp_2022_110626
crossref_primary_10_1016_j_schres_2024_02_019
crossref_primary_10_3390_cells10010183
crossref_primary_10_1016_j_psyneuen_2021_105392
crossref_primary_10_1016_j_schres_2024_06_034
crossref_primary_10_1192_j_eurpsy_2022_2333
crossref_primary_10_3390_brainsci12121666
crossref_primary_10_3390_molecules26051237
Cites_doi 10.1016/j.jpsychires.2011.09.022
10.1177/039463200401700316
10.1016/j.schres.2014.07.013
10.1186/s12888-014-0268-x
10.1016/j.jpsychires.2014.09.009
10.3109/08039488.2015.1087592
10.1016/j.psyneuen.2014.09.029
10.1016/j.schres.2014.07.033
10.1016/j.pneurobio.2011.04.003
10.1016/j.eurpsy.2016.03.005
10.1016/j.neulet.2013.09.059
10.1016/j.schres.2010.02.1063
10.1016/j.pnpbp.2014.09.014
10.1016/j.jpsychires.2013.05.032
10.1016/j.schres.2008.01.017
10.1016/j.jpsychires.2006.01.005
10.1016/j.schres.2014.10.030
10.1159/000369214
10.1016/j.schres.2013.07.030
10.1016/j.schres.2016.04.047
10.1007/978-1-61779-536-7_1
10.1007/s00213-014-3660-9
10.1016/bs.vh.2016.11.002
10.1016/j.pnpbp.2008.04.007
10.1017/neu.2014.13
10.1159/000205518
10.15171/ijhpm.2014.71
10.1038/mp.2010.88
10.1155/2014/978143
10.1186/1479-5876-10-239
10.1016/S0920-9964(00)00084-0
10.1016/S1044-5765(05)80028-4
10.1097/JCP.0b013e31821895c1
10.1038/mp.2014.117
10.1016/j.pnpbp.2014.01.012
10.1016/S0165-1781(02)00127-0
10.1016/j.schres.2009.07.022
10.1016/j.schres.2011.03.011
10.1016/j.psychres.2013.12.009
10.7326/0003-4819-151-4-200908180-00135
10.1017/S1461145711000150
10.1371/journal.pone.0087997
10.1080/15622975.2018.1433878
10.1016/j.euroneuro.2004.12.005
10.1002/ajmg.b.30338
10.1016/S0959-4388(00)00092-1
10.2174/1389203711209070658
10.1007/s00439-012-1150-x
10.1016/j.jclinepi.2009.06.006
10.1098/rstb.1996.0030
10.1016/j.schres.2009.12.035
10.3109/15622970802182733
10.1016/S0920-9964(02)00434-6
10.1111/sji.12158
10.1016/j.pnpbp.2004.05.008
10.1016/j.jpsychires.2017.05.009
10.1136/bmj.39343.408449.80
10.1016/j.jpsychires.2005.11.004
10.1016/j.neulet.2014.05.034
10.1016/j.schres.2004.08.004
10.1038/nrn.2017.125
10.1016/j.lfs.2013.01.008
10.1016/j.biopsych.2009.02.017
10.1097/NMD.0000000000000463
10.3389/fpsyt.2013.00045
10.1371/journal.pone.0189373
10.1007/s00213-012-2643-y
10.1016/j.jpsychires.2010.06.012
10.1016/j.clinbiochem.2014.03.021
10.1007/s00213-009-1665-6
10.1016/j.pscychresns.2015.08.009
10.1136/bmj.327.7414.557
10.1093/schbul/sbr070
10.1016/j.pnpbp.2011.09.004
10.1159/000315438
10.1017/S0033291714001925
10.1016/j.psychres.2016.07.040
10.1016/j.biopsych.2006.08.025
10.1016/j.jpsychires.2016.11.012
10.31887/DCNS.2000.2.4/ctamminga
10.1016/j.psychres.2012.11.020
10.1016/j.jpsychires.2006.08.007
10.1016/j.pnpbp.2009.08.011
10.1192/S0007125000292672
10.1016/j.bbi.2015.09.014
10.1016/j.psychres.2014.09.020
10.1016/j.psyneuen.2014.06.004
10.3390/ijms18040733
10.4088/JCP.13m08772
10.1002/hup.1257
10.1038/nature16874
10.1016/j.nbd.2010.04.017
10.1038/tp.2017.4
10.1016/j.pnpbp.2007.03.010
ContentType Journal Article
Copyright 2018 Elsevier Ltd
Copyright © 2018 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2018 Elsevier Ltd
– notice: Copyright © 2018 Elsevier Ltd. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jpsychires.2018.09.007
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1379
EndPage 53
ExternalDocumentID 10_1016_j_jpsychires_2018_09_007
30269004
S0022395618305934
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AACTN
AADFP
AADPK
AAEDT
AAEDW
AAGJA
AAGUQ
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
ABBQC
ABCQJ
ABFNM
ABIVO
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABOYX
ABPPZ
ABXDB
ABYKQ
ACDAQ
ACGFS
ACHQT
ACIUM
ACNCT
ACRLP
ACXNI
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AFYLN
AGHFR
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEG
HF~
HMK
HMO
HMQ
HMW
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LCYCR
M29
M2V
M39
M3V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SPS
SSB
SSH
SSN
SSY
SSZ
T5K
WUQ
YQT
Z5R
ZA5
ZGI
~G-
AAXKI
AFJKZ
AKRWK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c465t-f6898f950c32fc10b029498017612f4b76a1d993527d431ce43c00e11c407d5d3
IEDL.DBID .~1
ISSN 0022-3956
IngestDate Fri Oct 25 10:15:18 EDT 2024
Thu Sep 26 17:12:16 EDT 2024
Wed Oct 16 00:51:35 EDT 2024
Fri Feb 23 02:28:06 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License Copyright © 2018 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c465t-f6898f950c32fc10b029498017612f4b76a1d993527d431ce43c00e11c407d5d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ORCID 0000-0003-0051-9964
0000-0001-9899-9569
0000-0002-0114-2292
0000-0002-3723-6039
OpenAccessLink http://hdl.handle.net/1822/57939
PMID 30269004
PQID 2115274811
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_2115274811
crossref_primary_10_1016_j_jpsychires_2018_09_007
pubmed_primary_30269004
elsevier_sciencedirect_doi_10_1016_j_jpsychires_2018_09_007
PublicationCentury 2000
PublicationDate November 2018
2018-11-00
20181101
PublicationDateYYYYMMDD 2018-11-01
PublicationDate_xml – month: 11
  year: 2018
  text: November 2018
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of psychiatric research
PublicationTitleAlternate J Psychiatr Res
PublicationYear 2018
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Dhindsa, Goldstein (bib14) 2016
Lee, Kim (bib38) 2009; 59
Gratacòs, González, Mercader, de Cid, Urretavizcaya, Estivill (bib22) 2007; 61
Liberati, Altman, Tetzlaff, Mulrow, Gøtzsche, Ioannidis, Clarke, Devereaux, Kleijnen, Moher (bib42) 2009; 62
Xiu, Hui, Dang, De Hou, Zhang, Zheng, Chen, Kosten, Zhang (bib89) 2009; 33
Lindsay (bib43) 1996; 351
Rao, Chiappelli, Kochunov, Regenold, Rapaport, Hong (bib59) 2015; 15
Bakirhan, Sahiner, Sahiner, Safak, Goka (bib6) 2017; 12
Nandra, Agius (bib49) 2012
Agartz, Sedvall, Terenius, Kulle, Frigessi, Hall, Jönsson (bib1) 2006; 141
Carlino, Leone, Di Cola, Baj, Marin, Dinelli, Tongiorgi, De Vanna (bib11) 2011; 45
Nieto, Kukuljan, Silva (bib50) 2013; 4
Shoval, Weizman (bib69) 2005
Jindal, Pillai, Mahadik, Eklund, Montrose, Keshavan (bib32) 2010; 119
Zugman, Pedrini, Gadelha, Kempton, Noto, Mansur, Santoro, Gama, Bressan, McGuire, Jackowski, Brietzke (bib100) 2015; 234
Huang, Lee (bib28) 2006; 40
Wong, Rothmond, Webster, Weickert (bib84) 2013; 39
Bersani, Iannitelli, Massoni, Garavini, Grilli, Di Giannantonio, Conti, Pancheri (bib8) 2004; 17
Bellon, Krebs, Jay (bib7) 2011; 94
Rodrigues-Amorim, Rivera-Baltanás, López, Spuch, Olivares, Agís-Balboa (bib66) 2017; 93
Rizos, Papathanasiou, Michalopoulou, Laskos, Mazioti, Kastania, Vasilopoulou, Nikolaidou, Margaritis, Papageorgiou, Liappas (bib61) 2014; 9
Song, Fan, Li, Kennedy, Pang, Quan, Chen, Gao, Zhang, Zhang, Lv (bib72) 2014; 159
Rodrigues-Amorim, Rivera-Baltanás, Regueiro, Spuch, de las Heras, Váquez-Noguerol Méndez, Nieto-Araujo, Barreiro-Villar, Olivares, Agís-Balboa (bib67) 2018; 2975
Kim, Song, So, Lee, Song, Kim (bib35) 2014; 220
Sun, Liu, Guo, Jiang, Ma, Li, Tang, Ling (bib76) 2016; 244
Dong, Ruzicka, Grayson, Guidotti (bib15) 2015; 167
Pirildar, Gönül, Taneli, Akdeniz (bib57) 2004; 28
Grillo, Ottoni, Leke, Souza, Portela, Lara (bib24) 2007; 41
Lenhard, Lenhard (bib40) 2016
Zhang, Liang, Chen, Xiu, De Yang, Kosten, Kosten (bib97) 2012; 222
Aloe, Rocco, Bianchi, Manni (bib3) 2012; 10
Fernandes, Steiner, Berk, Molendijk, Gonzalez-Pinto, Turck, Nardin, Gonçalves (bib19) 2015; 20
Wu, Chen, Tan, Tan, Hui, Lv, Soares, Zhang (bib85) 2015; 232
Rizos, Michalopoulou, Siafakas, Stefanis, Douzenis, Rontos, Laskos, Kastania, Zoumpourlis, Lykouras (bib62) 2010; 62
Ikeda, Yahata, Ito, Nagano, Toyota, Yoshikawa, Okubo, Suzuki (bib29) 2008; 101
Zakharyan, Boyajyan (bib93) 2014; 47
Parikh, Evans, Khan, Mahadik (bib54) 2003; 60
Yamamori, Hashimoto, Ishima, Kishi, Yasuda, Ohi, Fujimoto, Umeda-Yano, Ito, Hashimoto, Takeda (bib90) 2013; 556
Loch, Zanetti, de Sousa, Chaim, Serpa, Gattaz, Teixeira, Machado-Vieira (bib44) 2015; 56
Munn, Moola, Riitano, Lisy (bib48) 2014; 3
Zhang, Tan, Chen, Tan, Yang, Wu, Zunta-Soares, Huang, Kosten, Soares (bib98) 2016; 51
Rao, Martínez-Cengotitabengoa, Yao, Guo, Xu, Li, Zhou, Zhang (bib60) 2017; 86
Rizos, Rontos, Laskos, Arsenis, Michalopoulou, Vasilopoulos, Gournellis, Lykouras (bib65) 2008; 32
Sahay, Sundrani, Joshi (bib68) 2017
Auta, Smith, Dong, Tueting, Sershen, Boules, Lajyha, Davis, Guidotti (bib5) 2013; 150
Ioannidis, Patsopoulos, Evangelou (bib30) 2007; 335
Skaper (bib70) 2012
Sun, Chen, Xia, Wang, Chen (bib75) 2013; 14
Yoshimura, Hori, Ikenouchi-Sugita, Umene-Nakano, Katsuki, Hayashi, Atake, Tomita, Nakamura (bib91) 2012; 27
Yoshimura, Hori, Sugita, Ueda, Kakihara, Umene, Nakano, Shinkai, Mitoma, Ohta, Shinkai, Nakamura (bib92) 2007; 31
Tamminga, Medoff (bib78) 2000; 2
Niitsu, Shirayama, Matsuzawa, Hasegawa, Kanahara, Hashimoto, Shiraishi, Shiina, Fukami, Fujisaki, Watanabe, Nakazato, Asano, Kimura, Hashimoto, Iyo (bib52) 2011; 35
Toyooka, Asama, Watanabe, Muratake, Takahashi, Someya, Nawa (bib81) 2002; 110
Zhang, Chen, Tan, Tan, Wang, Yang, Okusaga, Zunta-Soares, Soares (bib95) 2015; 51
Wysokiński (bib86) 2016; 70
Sotiropoulou, Mantas, Bozidis, Marselos, Mavreas, Hyphantis, Antoniou (bib74) 2013; 92
Rizos, Papathanasiou, Michalopoulou, Mazioti, Douzenis, Kastania, Nikolaidou, Laskos, Vasilopoulou, Lykouras (bib64) 2011; 129
Moher, Liberati, Tetzlaff, Altman (bib47) 2009; 151
Niitsu, Ishima, Yoshida, Hashimoto, Matsuzawa, Shirayama, Nakazato, Shimizu, Hashimoto, Iyo (bib51) 2014; 215
Asevedo, Gadelha, Noto, Mansur, Zugman, Belangero, Berberian, Scarpato, Leclerc, Teixeira, Gama, Bressan, Brietzke (bib4) 2013; 47
Favalli, Li, Belmonte-de-Abreu, Wong, Daskalakis (bib18) 2012
Li, Ye, Xiao, Tang, Sha, Zhang, Wang (bib41) 2016; 36
Theleritis, Fisher, Shäfer, Winters, Stahl, Morgan, Dazzan, Breedvelt, Sambath, Vitoratou, Russo, Reichenberg, Aurora Falcone, Mondelli, O'Connor, David, McGuire, Pariante, Di Forti, Murray, Bonaccorso (bib80) 2014; 159
Lee, Lange, Ricken, Hellweg, Lang (bib37) 2011; 31
Niitsu, Shirayama, Matsuzawa, Shimizu, Hashimoto, Iyo (bib53) 2014; 575
Syvälahti (bib77) 1994
Chen, Lee, Chang, Chen, Chu, Wang, Chen, Lee, Yang, Hong, Lu (bib13) 2014; 51
Birnbaum, Weinberger (bib9) 2017
Higgins, Thompson, Deeks, Altman (bib26) 2003; 327
Green, Matheson, Shepherd, Weickert, Carr (bib23) 2011; 16
Gonzalez-Liencres, Tas, Brown, Erdin, Onur, Cubukcoglu, Aydemir, Esen-Danaci, Brüne (bib21) 2014; 14
Skilleter, Weickert, Vercammen, Lenroot, Weickert (bib71) 2015; 45
Perkovic, Erjavec, Strac, Uzun, Kozumplik, Pivac (bib55) 2017
Chen, Wang, Wang, Yang, Zhang, Zheng, Li, Wang, Yang, Xiu, Kosten, Zhang (bib12) 2009; 207
Boyuk, Degirmencioglu, Atalay, Guzel, Acar, Celebi, Ekizoglu, Simsek (bib10) 2014; 2014
Song, Quan, Lv, Li, Pang, Kennedy, Hodge, Harrington, Ziedonis, Fan (bib73) 2015; 60
Zhang, Chen, Tan, Tan, Wang, Yang, Xiu, Hui, Lv, Zunta-Soares, Soares (bib96) 2014; 48
Lee, Nurjono, Lee (bib39) 2016; 204
Vinogradov, Fisher, Holland, Shelly, Wolkowitz, Mellon (bib83) 2009; 66
Mizuno, Hofer, Suzuki, Frajo-Apor, Wartelsteiner, Kemmler, Saruta, Tsukinoki, Mimura, Fleischhacker, Uchida (bib46) 2016; 175
van Kesteren, Gremmels, de Witte, Hol, Van Gool, Falkai, Kahn, Sommer (bib82) 2017; 7
Huang, Lee (bib27) 2006; 40
Zhang, Chen, Xiu, Haile, Luo, Xu, Zhang, Zhang, Zhang, Kosten, Kosten (bib94) 2012; 131
Durany, Michel, Zöchling, Boissl, Cruz-Sánchez, Riederer, Thome (bib16) 2001; 52
Xiong, Zeng, Wu, Huang, Zainal, Xu, Wan, Xu, Lu (bib87) 2014; 75
Tan, Zhou, Zhang (bib79) 2005; 74
Fumagalli, Calabrese, Luoni, Bolis, Racagni, Riva (bib20) 2012; 15
Gu, Ding, Yang, Liu (bib25) 2015
Zhang, Tan, Zhou, Cao, Wu, Xu, Shen, Haile, Kosten, Kosten (bib99) 2007; 41
Kaplan, Miller (bib34) 2000
Martinez-Cengotitabengoa, Macdowell, Alberich, Diaz, Garcia-Bueno, Rodriguez-Jimenez, Bioque, Berrocoso, Parellada, Lobo, Saiz, Matute, Bernardo, Gonzalez-Pinto, Leza (bib45) 2016; 42
Xiong, Zeng, Zhu, Tan, Xu, Lu, Wan, Ma (bib88) 2010; 119
Qin, Wu, Cao, Loh, Cheng (bib58) 2017
Eker, Yavasci, Cangur, Kirli, Sarandol (bib17) 2014; 26
Ajami, Hosseini, Taghipour, Khalilian (bib2) 2014; 80
Kale, Joshi, Pillai, Naphade, Raju, Nasrallah, Mahadik (bib33) 2009; 115
Issa, Wilson, Terry, Pillai (bib31) 2010; 39
Rizos, Papadopoulou, Laskos, Michalopoulou, Kastania, Vasilopoulos, Katsafouros, Lykouras (bib63) 2010; 11
Kuo, Lee, Hsieh, Kuo, Chen, Hung (bib36) 2013; 209
Persson (bib56) 1993; 5
Dhindsa (10.1016/j.jpsychires.2018.09.007_bib14) 2016
Auta (10.1016/j.jpsychires.2018.09.007_bib5) 2013; 150
Fernandes (10.1016/j.jpsychires.2018.09.007_bib19) 2015; 20
Rizos (10.1016/j.jpsychires.2018.09.007_bib63) 2010; 11
Yamamori (10.1016/j.jpsychires.2018.09.007_bib90) 2013; 556
Qin (10.1016/j.jpsychires.2018.09.007_bib58) 2017
Mizuno (10.1016/j.jpsychires.2018.09.007_bib46) 2016; 175
Gu (10.1016/j.jpsychires.2018.09.007_bib25) 2015
Syvälahti (10.1016/j.jpsychires.2018.09.007_bib77) 1994
Vinogradov (10.1016/j.jpsychires.2018.09.007_bib83) 2009; 66
Kim (10.1016/j.jpsychires.2018.09.007_bib35) 2014; 220
Song (10.1016/j.jpsychires.2018.09.007_bib72) 2014; 159
Green (10.1016/j.jpsychires.2018.09.007_bib23) 2011; 16
Loch (10.1016/j.jpsychires.2018.09.007_bib44) 2015; 56
Zakharyan (10.1016/j.jpsychires.2018.09.007_bib93) 2014; 47
Higgins (10.1016/j.jpsychires.2018.09.007_bib26) 2003; 327
Rodrigues-Amorim (10.1016/j.jpsychires.2018.09.007_bib66) 2017; 93
Eker (10.1016/j.jpsychires.2018.09.007_bib17) 2014; 26
Jindal (10.1016/j.jpsychires.2018.09.007_bib32) 2010; 119
Dong (10.1016/j.jpsychires.2018.09.007_bib15) 2015; 167
Rizos (10.1016/j.jpsychires.2018.09.007_bib64) 2011; 129
Xiu (10.1016/j.jpsychires.2018.09.007_bib89) 2009; 33
Huang (10.1016/j.jpsychires.2018.09.007_bib27) 2006; 40
Bersani (10.1016/j.jpsychires.2018.09.007_bib8) 2004; 17
Bakirhan (10.1016/j.jpsychires.2018.09.007_bib6) 2017; 12
Xiong (10.1016/j.jpsychires.2018.09.007_bib87) 2014; 75
Kuo (10.1016/j.jpsychires.2018.09.007_bib36) 2013; 209
Tan (10.1016/j.jpsychires.2018.09.007_bib79) 2005; 74
Carlino (10.1016/j.jpsychires.2018.09.007_bib11) 2011; 45
Huang (10.1016/j.jpsychires.2018.09.007_bib28) 2006; 40
Kale (10.1016/j.jpsychires.2018.09.007_bib33) 2009; 115
Moher (10.1016/j.jpsychires.2018.09.007_bib47) 2009; 151
Nandra (10.1016/j.jpsychires.2018.09.007_bib49) 2012
Tamminga (10.1016/j.jpsychires.2018.09.007_bib78) 2000; 2
Durany (10.1016/j.jpsychires.2018.09.007_bib16) 2001; 52
Chen (10.1016/j.jpsychires.2018.09.007_bib12) 2009; 207
Yoshimura (10.1016/j.jpsychires.2018.09.007_bib91) 2012; 27
Toyooka (10.1016/j.jpsychires.2018.09.007_bib81) 2002; 110
Lenhard (10.1016/j.jpsychires.2018.09.007_bib40) 2016
Ioannidis (10.1016/j.jpsychires.2018.09.007_bib30) 2007; 335
Ikeda (10.1016/j.jpsychires.2018.09.007_bib29) 2008; 101
Skaper (10.1016/j.jpsychires.2018.09.007_bib70) 2012
Ajami (10.1016/j.jpsychires.2018.09.007_bib2) 2014; 80
Lee (10.1016/j.jpsychires.2018.09.007_bib37) 2011; 31
Agartz (10.1016/j.jpsychires.2018.09.007_bib1) 2006; 141
Rao (10.1016/j.jpsychires.2018.09.007_bib60) 2017; 86
Gonzalez-Liencres (10.1016/j.jpsychires.2018.09.007_bib21) 2014; 14
Niitsu (10.1016/j.jpsychires.2018.09.007_bib51) 2014; 215
Lee (10.1016/j.jpsychires.2018.09.007_bib39) 2016; 204
Aloe (10.1016/j.jpsychires.2018.09.007_bib3) 2012; 10
Nieto (10.1016/j.jpsychires.2018.09.007_bib50) 2013; 4
Zugman (10.1016/j.jpsychires.2018.09.007_bib100) 2015; 234
Lindsay (10.1016/j.jpsychires.2018.09.007_bib43) 1996; 351
Issa (10.1016/j.jpsychires.2018.09.007_bib31) 2010; 39
Pirildar (10.1016/j.jpsychires.2018.09.007_bib57) 2004; 28
Bellon (10.1016/j.jpsychires.2018.09.007_bib7) 2011; 94
Sun (10.1016/j.jpsychires.2018.09.007_bib75) 2013; 14
Boyuk (10.1016/j.jpsychires.2018.09.007_bib10) 2014; 2014
Yoshimura (10.1016/j.jpsychires.2018.09.007_bib92) 2007; 31
Shoval (10.1016/j.jpsychires.2018.09.007_bib69) 2005
Wu (10.1016/j.jpsychires.2018.09.007_bib85) 2015; 232
Niitsu (10.1016/j.jpsychires.2018.09.007_bib52) 2011; 35
Zhang (10.1016/j.jpsychires.2018.09.007_bib95) 2015; 51
van Kesteren (10.1016/j.jpsychires.2018.09.007_bib82) 2017; 7
Asevedo (10.1016/j.jpsychires.2018.09.007_bib4) 2013; 47
Favalli (10.1016/j.jpsychires.2018.09.007_bib18) 2012
Zhang (10.1016/j.jpsychires.2018.09.007_bib98) 2016; 51
Kaplan (10.1016/j.jpsychires.2018.09.007_bib34) 2000
Fumagalli (10.1016/j.jpsychires.2018.09.007_bib20) 2012; 15
Sun (10.1016/j.jpsychires.2018.09.007_bib76) 2016; 244
Chen (10.1016/j.jpsychires.2018.09.007_bib13) 2014; 51
Rodrigues-Amorim (10.1016/j.jpsychires.2018.09.007_bib67) 2018; 2975
Perkovic (10.1016/j.jpsychires.2018.09.007_bib55) 2017
Skilleter (10.1016/j.jpsychires.2018.09.007_bib71) 2015; 45
Persson (10.1016/j.jpsychires.2018.09.007_bib56) 1993; 5
Zhang (10.1016/j.jpsychires.2018.09.007_bib94) 2012; 131
Rao (10.1016/j.jpsychires.2018.09.007_bib59) 2015; 15
Theleritis (10.1016/j.jpsychires.2018.09.007_bib80) 2014; 159
Rizos (10.1016/j.jpsychires.2018.09.007_bib62) 2010; 62
Zhang (10.1016/j.jpsychires.2018.09.007_bib96) 2014; 48
Birnbaum (10.1016/j.jpsychires.2018.09.007_bib9) 2017
Munn (10.1016/j.jpsychires.2018.09.007_bib48) 2014; 3
Xiong (10.1016/j.jpsychires.2018.09.007_bib88) 2010; 119
Zhang (10.1016/j.jpsychires.2018.09.007_bib99) 2007; 41
Parikh (10.1016/j.jpsychires.2018.09.007_bib54) 2003; 60
Wong (10.1016/j.jpsychires.2018.09.007_bib84) 2013; 39
Lee (10.1016/j.jpsychires.2018.09.007_bib38) 2009; 59
Gratacòs (10.1016/j.jpsychires.2018.09.007_bib22) 2007; 61
Sotiropoulou (10.1016/j.jpsychires.2018.09.007_bib74) 2013; 92
Rizos (10.1016/j.jpsychires.2018.09.007_bib65) 2008; 32
Zhang (10.1016/j.jpsychires.2018.09.007_bib97) 2012; 222
Liberati (10.1016/j.jpsychires.2018.09.007_bib42) 2009; 62
Li (10.1016/j.jpsychires.2018.09.007_bib41) 2016; 36
Grillo (10.1016/j.jpsychires.2018.09.007_bib24) 2007; 41
Song (10.1016/j.jpsychires.2018.09.007_bib73) 2015; 60
Rizos (10.1016/j.jpsychires.2018.09.007_bib61) 2014; 9
Wysokiński (10.1016/j.jpsychires.2018.09.007_bib86) 2016; 70
Niitsu (10.1016/j.jpsychires.2018.09.007_bib53) 2014; 575
Sahay (10.1016/j.jpsychires.2018.09.007_bib68) 2017
Martinez-Cengotitabengoa (10.1016/j.jpsychires.2018.09.007_bib45) 2016; 42
References_xml – volume: 52
  start-page: 79
  year: 2001
  end-page: 86
  ident: bib16
  article-title: Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
  publication-title: Schizophr. Res.
  contributor:
    fullname: Thome
– year: 2017
  ident: bib9
  article-title: Genetic insights into the neurodevelopmental origins of schizophrenia
  publication-title: Nat. Rev. Neurosci.
  contributor:
    fullname: Weinberger
– volume: 70
  start-page: 267
  year: 2016
  end-page: 271
  ident: bib86
  article-title: Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia
  publication-title: Nord. J. Psychiatr.
  contributor:
    fullname: Wysokiński
– volume: 167
  start-page: 35
  year: 2015
  end-page: 41
  ident: bib15
  article-title: DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients
  publication-title: Schizophr. Res.
  contributor:
    fullname: Guidotti
– volume: 51
  start-page: 169
  year: 2016
  end-page: 175
  ident: bib98
  article-title: Interaction of BDNF with cytokines in chronic schizophrenia
  publication-title: Brain Behav. Immun.
  contributor:
    fullname: Soares
– volume: 351
  start-page: 365
  year: 1996
  end-page: 373
  ident: bib43
  article-title: Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview
  publication-title: Philos. Trans. R. Soc. B Biol. Sci.
  contributor:
    fullname: Lindsay
– volume: 16
  start-page: 960
  year: 2011
  end-page: 972
  ident: bib23
  article-title: Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
  publication-title: Mol. Psychiatr.
  contributor:
    fullname: Carr
– volume: 204
  start-page: 636
  year: 2016
  end-page: 639
  ident: bib39
  article-title: Levels of serum brain-derived neurotrophic factor in schizophrenia
  publication-title: J. Nerv. Ment. Dis.
  contributor:
    fullname: Lee
– volume: 62
  start-page: e1
  year: 2009
  end-page: 34
  ident: bib42
  article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
  publication-title: J. Clin. Epidemiol.
  contributor:
    fullname: Moher
– start-page: 243
  year: 2017
  end-page: 261
  ident: bib68
  article-title: Neurotrophins: role in placental growth and development
  publication-title: Vitamins and Hormones
  contributor:
    fullname: Joshi
– volume: 209
  start-page: 150
  year: 2013
  end-page: 154
  ident: bib36
  article-title: Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic patients with schizophrenia
  publication-title: Psychiatr. Res.
  contributor:
    fullname: Hung
– volume: 28
  start-page: 709
  year: 2004
  end-page: 713
  ident: bib57
  article-title: Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Akdeniz
– volume: 131
  start-page: 1187
  year: 2012
  end-page: 1195
  ident: bib94
  article-title: Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls
  publication-title: Hum. Genet.
  contributor:
    fullname: Kosten
– volume: 141
  start-page: 513
  year: 2006
  end-page: 523
  ident: bib1
  article-title: BDNF gene variants and brain morphology in schizophrenia
  publication-title: Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
  contributor:
    fullname: Jönsson
– volume: 110
  start-page: 249
  year: 2002
  end-page: 257
  ident: bib81
  article-title: Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients
  publication-title: Psychiatr. Res.
  contributor:
    fullname: Nawa
– volume: 39
  start-page: 327
  year: 2010
  end-page: 333
  ident: bib31
  article-title: An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies
  publication-title: Neurobiol. Dis.
  contributor:
    fullname: Pillai
– volume: 215
  start-page: 268
  year: 2014
  end-page: 273
  ident: bib51
  article-title: A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia
  publication-title: Psychiatr. Res.
  contributor:
    fullname: Iyo
– volume: 244
  start-page: 370
  year: 2016
  end-page: 375
  ident: bib76
  article-title: Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture
  publication-title: Psychiatr. Res.
  contributor:
    fullname: Ling
– volume: 51
  start-page: 201
  year: 2015
  end-page: 208
  ident: bib95
  article-title: The interplay between BDNF and oxidative stress in chronic schizophrenia
  publication-title: Psychoneuroendocrinology
  contributor:
    fullname: Soares
– volume: 575
  start-page: 37
  year: 2014
  end-page: 41
  ident: bib53
  article-title: Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia
  publication-title: Neurosci. Lett.
  contributor:
    fullname: Iyo
– volume: 94
  start-page: 77
  year: 2011
  end-page: 90
  ident: bib7
  article-title: Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia
  publication-title: Prog. Neurobiol.
  contributor:
    fullname: Jay
– volume: 14
  start-page: 617
  year: 2013
  end-page: 625
  ident: bib75
  article-title: Functional switch from pro-neurotrophins to mature neurotrophins
  publication-title: Curr. Protein Pept. Sci.
  contributor:
    fullname: Chen
– volume: 2014
  start-page: 1
  year: 2014
  end-page: 6
  ident: bib10
  article-title: Relationship between levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus
  publication-title: J. Diabetes Res.
  contributor:
    fullname: Simsek
– volume: 151
  start-page: 264
  year: 2009
  end-page: 269
  ident: bib47
  article-title: Preferred reporting Items for systematic reviews and MetaAnalyses: the PRISMA statement
  publication-title: Ann. Intern. Med.
  contributor:
    fullname: Altman
– volume: 207
  start-page: 375
  year: 2009
  end-page: 380
  ident: bib12
  article-title: Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes
  publication-title: Psychopharmacology (Berlin)
  contributor:
    fullname: Zhang
– start-page: 1
  year: 2017
  end-page: 7
  ident: bib58
  article-title: A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
  publication-title: Mol. Psychiatr.
  contributor:
    fullname: Cheng
– volume: 327
  start-page: 557
  year: 2003
  end-page: 560
  ident: bib26
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ Br. Med. J. (Clin. Res. Ed.)
  contributor:
    fullname: Altman
– volume: 11
  start-page: 251
  year: 2010
  end-page: 255
  ident: bib63
  article-title: Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics
  publication-title: World J. Biol. Psychiatr.
  contributor:
    fullname: Lykouras
– start-page: 73
  year: 2015
  end-page: 99
  ident: bib25
  article-title: Tissue engineering in peripheral nerve regeneration
  publication-title: Neural Regeneration
  contributor:
    fullname: Liu
– volume: 51
  start-page: 99
  year: 2014
  end-page: 104
  ident: bib13
  article-title: The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Lu
– volume: 40
  start-page: 664
  year: 2006
  end-page: 668
  ident: bib28
  article-title: Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Lee
– volume: 10
  start-page: 1
  year: 2012
  end-page: 15
  ident: bib3
  article-title: Nerve growth factor: from the early discoveries to the potential clinical use
  publication-title: J. Transl. Med.
  contributor:
    fullname: Manni
– volume: 45
  start-page: 841
  year: 2015
  end-page: 854
  ident: bib71
  article-title: Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
  publication-title: Psychol. Med.
  contributor:
    fullname: Weickert
– volume: 119
  start-page: 47
  year: 2010
  end-page: 51
  ident: bib32
  article-title: Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia
  publication-title: Schizophr. Res.
  contributor:
    fullname: Keshavan
– volume: 129
  start-page: 201
  year: 2011
  end-page: 204
  ident: bib64
  article-title: Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients
  publication-title: Schizophr. Res.
  contributor:
    fullname: Lykouras
– volume: 159
  start-page: 56
  year: 2014
  end-page: 61
  ident: bib80
  article-title: Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis
  publication-title: Schizophr. Res.
  contributor:
    fullname: Bonaccorso
– volume: 26
  start-page: 291
  year: 2014
  end-page: 297
  ident: bib17
  article-title: Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
  publication-title: Acta Neuropsychiatr.
  contributor:
    fullname: Sarandol
– start-page: 95
  year: 2012
  end-page: 99
  ident: bib49
  article-title: The differences between typical and atypical antipsychotics: the effects on neurogenesis
  publication-title: Psychiatria Danubina
  contributor:
    fullname: Agius
– volume: 62
  start-page: 87
  year: 2010
  end-page: 90
  ident: bib62
  article-title: Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia
  publication-title: Neuropsychobiology
  contributor:
    fullname: Lykouras
– volume: 33
  start-page: 1508
  year: 2009
  end-page: 1512
  ident: bib89
  article-title: Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Zhang
– volume: 48
  start-page: 136
  year: 2014
  end-page: 146
  ident: bib96
  article-title: Gender difference in association of cognition with BDNF in chronic schizophrenia
  publication-title: Psychoneuroendocrinology
  contributor:
    fullname: Soares
– volume: 175
  start-page: 148
  year: 2016
  end-page: 153
  ident: bib46
  article-title: Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: a cross-sectional study
  publication-title: Schizophr. Res.
  contributor:
    fullname: Uchida
– volume: 40
  start-page: 664
  year: 2006
  end-page: 668
  ident: bib27
  article-title: Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Lee
– volume: 2975
  start-page: 1
  year: 2018
  end-page: 49
  ident: bib67
  article-title: The role of the gut microbiota in schizophrenia: current and future perspectives
  publication-title: World J. Biol. Psychiatr.
  contributor:
    fullname: Agís-Balboa
– volume: 12
  year: 2017
  ident: bib6
  article-title: Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia
  publication-title: PLoS One
  contributor:
    fullname: Goka
– volume: 80
  start-page: 36
  year: 2014
  end-page: 42
  ident: bib2
  article-title: Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment
  publication-title: Scand. J. Immunol.
  contributor:
    fullname: Khalilian
– volume: 41
  start-page: 31
  year: 2007
  end-page: 35
  ident: bib24
  article-title: Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Lara
– volume: 60
  start-page: 117
  year: 2003
  end-page: 123
  ident: bib54
  article-title: Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome
  publication-title: Schizophr. Res.
  contributor:
    fullname: Mahadik
– year: 2000
  ident: bib34
  article-title: Neurotrophin signal transduction in the nervous system
  publication-title: Curr. Opin. Neurobiol.
  contributor:
    fullname: Miller
– volume: 222
  start-page: 277
  year: 2012
  end-page: 284
  ident: bib97
  article-title: Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
  publication-title: Psychopharmacology (Berlin)
  contributor:
    fullname: Kosten
– start-page: 9
  year: 1994
  end-page: 14
  ident: bib77
  article-title: Biological factors in schizophrenia. Structural and functional aspects
  publication-title: Br. J. Psychiatr. Suppl.
  contributor:
    fullname: Syvälahti
– volume: 5
  start-page: 227
  year: 1993
  end-page: 237
  ident: bib56
  article-title: Neurotrophin production in the brain
  publication-title: Semin. Neurosci.
  contributor:
    fullname: Persson
– volume: 159
  start-page: 51
  year: 2014
  end-page: 55
  ident: bib72
  article-title: Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia
  publication-title: Schizophr. Res.
  contributor:
    fullname: Lv
– volume: 17
  start-page: 367
  year: 2004
  end-page: 372
  ident: bib8
  article-title: Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects
  publication-title: Int. J. Immunopathol. Pharmacol.
  contributor:
    fullname: Pancheri
– volume: 75
  start-page: e794
  year: 2014
  end-page: e801
  ident: bib87
  article-title: Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration
  publication-title: J. Clin. Psychiatr.
  contributor:
    fullname: Lu
– volume: 59
  start-page: 51
  year: 2009
  end-page: 58
  ident: bib38
  article-title: Increased plasma brain-derived neurotropic factor, not nerve growth factor-beta, in schizophrenia patients with better response to risperidone treatment
  publication-title: Neuropsychobiology
  contributor:
    fullname: Kim
– volume: 220
  start-page: 792
  year: 2014
  end-page: 796
  ident: bib35
  article-title: Increase of circulating BDNF levels and its relation to improvement of physical fitness following 12 weeks of combined exercise in chronic patients with schizophrenia: a pilot study
  publication-title: Psychiatr. Res.
  contributor:
    fullname: Kim
– volume: 14
  start-page: 1
  year: 2014
  end-page: 9
  ident: bib21
  article-title: Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
  publication-title: BMC Psychiatr.
  contributor:
    fullname: Brüne
– volume: 150
  start-page: 312
  year: 2013
  end-page: 318
  ident: bib5
  article-title: Blood lymphocytes of schizophrenia patients
  publication-title: Schizophr. Res.
  contributor:
    fullname: Guidotti
– year: 2016
  ident: bib14
  article-title: Schizophrenia: from genetics to physiology at last
  publication-title: Nature
  contributor:
    fullname: Goldstein
– year: 2017
  ident: bib55
  article-title: Theranostic biomarkers for schizophrenia
  publication-title: Int. J. Mol. Sci.
  contributor:
    fullname: Pivac
– volume: 9
  start-page: 1
  year: 2014
  end-page: 8
  ident: bib61
  article-title: A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia
  publication-title: PLoS One
  contributor:
    fullname: Liappas
– volume: 92
  start-page: 305
  year: 2013
  end-page: 310
  ident: bib74
  article-title: BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism
  publication-title: Life Sci.
  contributor:
    fullname: Antoniou
– volume: 31
  start-page: 334
  year: 2011
  end-page: 336
  ident: bib37
  article-title: Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment
  publication-title: J. Clin. Psychopharmacol.
  contributor:
    fullname: Lang
– volume: 35
  start-page: 1836
  year: 2011
  end-page: 1840
  ident: bib52
  article-title: Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Iyo
– year: 2016
  ident: bib40
  article-title: Calculation of effect sizes
  publication-title: Dettelbach Psychom
  contributor:
    fullname: Lenhard
– volume: 4
  start-page: 1
  year: 2013
  end-page: 11
  ident: bib50
  article-title: BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory
  publication-title: Front. Psychiatr.
  contributor:
    fullname: Silva
– volume: 31
  start-page: 1072
  year: 2007
  end-page: 1077
  ident: bib92
  article-title: Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Nakamura
– volume: 234
  start-page: 84
  year: 2015
  end-page: 89
  ident: bib100
  article-title: Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls
  publication-title: Psychiatry Res. Neuroimaging.
  contributor:
    fullname: Brietzke
– volume: 115
  start-page: 209
  year: 2009
  end-page: 214
  ident: bib33
  article-title: Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients
  publication-title: Schizophr. Res.
  contributor:
    fullname: Mahadik
– volume: 86
  start-page: 39
  year: 2017
  end-page: 45
  ident: bib60
  article-title: Peripheral blood nerve growth factor levels in major psychiatric disorders
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Zhang
– year: 2012
  ident: bib18
  article-title: The role of BDNF in the pathophysiology and treatment of schizophrenia
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Daskalakis
– volume: 2
  start-page: 339
  year: 2000
  end-page: 348
  ident: bib78
  article-title: The biology of schizophrenia
  publication-title: Dialogues Clin. Neurosci.
  contributor:
    fullname: Medoff
– year: 2005
  ident: bib69
  article-title: The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia
  publication-title: Eur. Neuropsychopharmacol
  contributor:
    fullname: Weizman
– volume: 41
  start-page: 997
  year: 2007
  end-page: 1004
  ident: bib99
  article-title: Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Kosten
– volume: 15
  start-page: 235
  year: 2012
  end-page: 246
  ident: bib20
  article-title: Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress
  publication-title: Int. J. Neuropsychopharmacol.
  contributor:
    fullname: Riva
– volume: 56
  start-page: 243
  year: 2015
  end-page: 246
  ident: bib44
  article-title: Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Machado-Vieira
– volume: 101
  start-page: 58
  year: 2008
  end-page: 66
  ident: bib29
  article-title: Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia
  publication-title: Schizophr. Res.
  contributor:
    fullname: Suzuki
– volume: 42
  start-page: 142
  year: 2016
  end-page: 151
  ident: bib45
  article-title: BDNF and NGF signalling in early phases of psychosis: relationship with inflammation and response to antipsychotics after 1 year
  publication-title: Schizophr. Bull.
  contributor:
    fullname: Leza
– volume: 66
  year: 2009
  ident: bib83
  article-title: Is serum brain-derived neurotrophic factor (BDNF) a biomarker for cognitive enhancement in schizophrenia?
  publication-title: Biol. Psychiatr.
  contributor:
    fullname: Mellon
– volume: 45
  start-page: 273
  year: 2011
  end-page: 279
  ident: bib11
  article-title: Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: De Vanna
– volume: 93
  start-page: 37
  year: 2017
  end-page: 49
  ident: bib66
  article-title: Schizophrenia: a review of potential biomarkers
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Agís-Balboa
– volume: 61
  start-page: 911
  year: 2007
  end-page: 922
  ident: bib22
  article-title: Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia
  publication-title: Biol. Psychiatr.
  contributor:
    fullname: Estivill
– volume: 20
  start-page: 1108
  year: 2015
  end-page: 1119
  ident: bib19
  article-title: Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications
  publication-title: Mol. Psychiatr.
  contributor:
    fullname: Gonçalves
– volume: 47
  start-page: 1052
  year: 2014
  end-page: 1055
  ident: bib93
  article-title: Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes
  publication-title: Clin. Biochem.
  contributor:
    fullname: Boyajyan
– volume: 335
  start-page: 914
  year: 2007
  end-page: 916
  ident: bib30
  article-title: Uncertainty in heterogeneity estimates in meta-analyses
  publication-title: BMJ
  contributor:
    fullname: Evangelou
– volume: 556
  start-page: 37
  year: 2013
  end-page: 41
  ident: bib90
  article-title: Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine
  publication-title: Neurosci. Lett.
  contributor:
    fullname: Takeda
– volume: 7
  start-page: e1075
  year: 2017
  ident: bib82
  article-title: Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
  publication-title: Transl. Psychiatry
  contributor:
    fullname: Sommer
– volume: 3
  start-page: 123
  year: 2014
  end-page: 128
  ident: bib48
  article-title: The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence
  publication-title: Int. J. Health Pol. Manag.
  contributor:
    fullname: Lisy
– volume: 36
  start-page: 23
  year: 2016
  end-page: 28
  ident: bib41
  article-title: Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia
  publication-title: Eur. Psychiatr.
  contributor:
    fullname: Wang
– volume: 32
  start-page: 1308
  year: 2008
  end-page: 1311
  ident: bib65
  article-title: Investigation of serum BDNF levels in drug-naive patients with schizophrenia
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  contributor:
    fullname: Lykouras
– volume: 74
  start-page: 263
  year: 2005
  end-page: 270
  ident: bib79
  article-title: Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements
  publication-title: Schizophr. Res.
  contributor:
    fullname: Zhang
– volume: 15
  start-page: 38
  year: 2015
  end-page: 44
  ident: bib59
  article-title: Is schizophrenia a neurodegenerative disease? Evidence from of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched non-psychiatric controls
  publication-title: Neurodegener. Dis.
  contributor:
    fullname: Hong
– volume: 39
  start-page: 130
  year: 2013
  end-page: 140
  ident: bib84
  article-title: Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia
  publication-title: Schizophr. Bull.
  contributor:
    fullname: Weickert
– volume: 60
  start-page: 22
  year: 2015
  end-page: 28
  ident: bib73
  article-title: Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Fan
– volume: 47
  start-page: 1376
  year: 2013
  end-page: 1382
  ident: bib4
  article-title: Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
  publication-title: J. Psychiatr. Res.
  contributor:
    fullname: Brietzke
– volume: 232
  start-page: 223
  year: 2015
  end-page: 232
  ident: bib85
  article-title: Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia
  publication-title: Psychopharmacology (Berlin)
  contributor:
    fullname: Zhang
– volume: 27
  start-page: 33
  year: 2012
  end-page: 38
  ident: bib91
  article-title: Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients
  publication-title: Hum. Psychopharmacol. Clin. Exp.
  contributor:
    fullname: Nakamura
– volume: 119
  start-page: 34
  year: 2010
  end-page: 39
  ident: bib88
  article-title: Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia
  publication-title: Schizophr. Res.
  contributor:
    fullname: Ma
– start-page: 1
  year: 2012
  end-page: 12
  ident: bib70
  article-title: The neurotrophin family of neurotrophic factors: an overview
  publication-title: Methods in Molecular Biology
  contributor:
    fullname: Skaper
– year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib18
  article-title: The role of BDNF in the pathophysiology and treatment of schizophrenia
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2011.09.022
  contributor:
    fullname: Favalli
– start-page: 95
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib49
  article-title: The differences between typical and atypical antipsychotics: the effects on neurogenesis
  contributor:
    fullname: Nandra
– volume: 17
  start-page: 367
  year: 2004
  ident: 10.1016/j.jpsychires.2018.09.007_bib8
  article-title: Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects
  publication-title: Int. J. Immunopathol. Pharmacol.
  doi: 10.1177/039463200401700316
  contributor:
    fullname: Bersani
– volume: 159
  start-page: 56
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib80
  article-title: Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2014.07.013
  contributor:
    fullname: Theleritis
– start-page: 1
  year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib58
  article-title: A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia
  publication-title: Mol. Psychiatr.
  contributor:
    fullname: Qin
– volume: 14
  start-page: 1
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib21
  article-title: Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
  publication-title: BMC Psychiatr.
  doi: 10.1186/s12888-014-0268-x
  contributor:
    fullname: Gonzalez-Liencres
– year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib40
  article-title: Calculation of effect sizes
  publication-title: Dettelbach Psychom
  contributor:
    fullname: Lenhard
– volume: 60
  start-page: 22
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib73
  article-title: Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2014.09.009
  contributor:
    fullname: Song
– volume: 70
  start-page: 267
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib86
  article-title: Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia
  publication-title: Nord. J. Psychiatr.
  doi: 10.3109/08039488.2015.1087592
  contributor:
    fullname: Wysokiński
– volume: 51
  start-page: 201
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib95
  article-title: The interplay between BDNF and oxidative stress in chronic schizophrenia
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2014.09.029
  contributor:
    fullname: Zhang
– volume: 159
  start-page: 51
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib72
  article-title: Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2014.07.033
  contributor:
    fullname: Song
– volume: 94
  start-page: 77
  year: 2011
  ident: 10.1016/j.jpsychires.2018.09.007_bib7
  article-title: Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia
  publication-title: Prog. Neurobiol.
  doi: 10.1016/j.pneurobio.2011.04.003
  contributor:
    fullname: Bellon
– volume: 36
  start-page: 23
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib41
  article-title: Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia
  publication-title: Eur. Psychiatr.
  doi: 10.1016/j.eurpsy.2016.03.005
  contributor:
    fullname: Li
– volume: 556
  start-page: 37
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib90
  article-title: Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2013.09.059
  contributor:
    fullname: Yamamori
– volume: 119
  start-page: 34
  year: 2010
  ident: 10.1016/j.jpsychires.2018.09.007_bib88
  article-title: Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2010.02.1063
  contributor:
    fullname: Xiong
– volume: 56
  start-page: 243
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib44
  article-title: Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2014.09.014
  contributor:
    fullname: Loch
– volume: 47
  start-page: 1376
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib4
  article-title: Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2013.05.032
  contributor:
    fullname: Asevedo
– volume: 101
  start-page: 58
  year: 2008
  ident: 10.1016/j.jpsychires.2018.09.007_bib29
  article-title: Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2008.01.017
  contributor:
    fullname: Ikeda
– volume: 41
  start-page: 31
  year: 2007
  ident: 10.1016/j.jpsychires.2018.09.007_bib24
  article-title: Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2006.01.005
  contributor:
    fullname: Grillo
– volume: 167
  start-page: 35
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib15
  article-title: DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2014.10.030
  contributor:
    fullname: Dong
– volume: 15
  start-page: 38
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib59
  article-title: Is schizophrenia a neurodegenerative disease? Evidence from of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched non-psychiatric controls
  publication-title: Neurodegener. Dis.
  doi: 10.1159/000369214
  contributor:
    fullname: Rao
– volume: 150
  start-page: 312
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib5
  article-title: Blood lymphocytes of schizophrenia patients
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2013.07.030
  contributor:
    fullname: Auta
– volume: 175
  start-page: 148
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib46
  article-title: Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: a cross-sectional study
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2016.04.047
  contributor:
    fullname: Mizuno
– start-page: 1
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib70
  article-title: The neurotrophin family of neurotrophic factors: an overview
  doi: 10.1007/978-1-61779-536-7_1
  contributor:
    fullname: Skaper
– volume: 232
  start-page: 223
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib85
  article-title: Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia
  publication-title: Psychopharmacology (Berlin)
  doi: 10.1007/s00213-014-3660-9
  contributor:
    fullname: Wu
– start-page: 243
  year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib68
  article-title: Neurotrophins: role in placental growth and development
  doi: 10.1016/bs.vh.2016.11.002
  contributor:
    fullname: Sahay
– volume: 32
  start-page: 1308
  year: 2008
  ident: 10.1016/j.jpsychires.2018.09.007_bib65
  article-title: Investigation of serum BDNF levels in drug-naive patients with schizophrenia
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2008.04.007
  contributor:
    fullname: Rizos
– volume: 26
  start-page: 291
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib17
  article-title: Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
  publication-title: Acta Neuropsychiatr.
  doi: 10.1017/neu.2014.13
  contributor:
    fullname: Eker
– volume: 59
  start-page: 51
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib38
  article-title: Increased plasma brain-derived neurotropic factor, not nerve growth factor-beta, in schizophrenia patients with better response to risperidone treatment
  publication-title: Neuropsychobiology
  doi: 10.1159/000205518
  contributor:
    fullname: Lee
– volume: 3
  start-page: 123
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib48
  article-title: The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence
  publication-title: Int. J. Health Pol. Manag.
  doi: 10.15171/ijhpm.2014.71
  contributor:
    fullname: Munn
– volume: 16
  start-page: 960
  year: 2011
  ident: 10.1016/j.jpsychires.2018.09.007_bib23
  article-title: Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
  publication-title: Mol. Psychiatr.
  doi: 10.1038/mp.2010.88
  contributor:
    fullname: Green
– volume: 2014
  start-page: 1
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib10
  article-title: Relationship between levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus
  publication-title: J. Diabetes Res.
  doi: 10.1155/2014/978143
  contributor:
    fullname: Boyuk
– volume: 10
  start-page: 1
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib3
  article-title: Nerve growth factor: from the early discoveries to the potential clinical use
  publication-title: J. Transl. Med.
  doi: 10.1186/1479-5876-10-239
  contributor:
    fullname: Aloe
– volume: 52
  start-page: 79
  year: 2001
  ident: 10.1016/j.jpsychires.2018.09.007_bib16
  article-title: Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
  publication-title: Schizophr. Res.
  doi: 10.1016/S0920-9964(00)00084-0
  contributor:
    fullname: Durany
– volume: 5
  start-page: 227
  year: 1993
  ident: 10.1016/j.jpsychires.2018.09.007_bib56
  article-title: Neurotrophin production in the brain
  publication-title: Semin. Neurosci.
  doi: 10.1016/S1044-5765(05)80028-4
  contributor:
    fullname: Persson
– volume: 31
  start-page: 334
  year: 2011
  ident: 10.1016/j.jpsychires.2018.09.007_bib37
  article-title: Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment
  publication-title: J. Clin. Psychopharmacol.
  doi: 10.1097/JCP.0b013e31821895c1
  contributor:
    fullname: Lee
– volume: 20
  start-page: 1108
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib19
  article-title: Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications
  publication-title: Mol. Psychiatr.
  doi: 10.1038/mp.2014.117
  contributor:
    fullname: Fernandes
– volume: 51
  start-page: 99
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib13
  article-title: The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2014.01.012
  contributor:
    fullname: Chen
– volume: 110
  start-page: 249
  year: 2002
  ident: 10.1016/j.jpsychires.2018.09.007_bib81
  article-title: Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients
  publication-title: Psychiatr. Res.
  doi: 10.1016/S0165-1781(02)00127-0
  contributor:
    fullname: Toyooka
– volume: 115
  start-page: 209
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib33
  article-title: Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2009.07.022
  contributor:
    fullname: Kale
– volume: 129
  start-page: 201
  year: 2011
  ident: 10.1016/j.jpsychires.2018.09.007_bib64
  article-title: Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2011.03.011
  contributor:
    fullname: Rizos
– volume: 215
  start-page: 268
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib51
  article-title: A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia
  publication-title: Psychiatr. Res.
  doi: 10.1016/j.psychres.2013.12.009
  contributor:
    fullname: Niitsu
– volume: 151
  start-page: 264
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib47
  article-title: Preferred reporting Items for systematic reviews and MetaAnalyses: the PRISMA statement
  publication-title: Ann. Intern. Med.
  doi: 10.7326/0003-4819-151-4-200908180-00135
  contributor:
    fullname: Moher
– volume: 15
  start-page: 235
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib20
  article-title: Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress
  publication-title: Int. J. Neuropsychopharmacol.
  doi: 10.1017/S1461145711000150
  contributor:
    fullname: Fumagalli
– volume: 9
  start-page: 1
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib61
  article-title: A longitudinal study of alterations of hippocampal volumes and serum BDNF levels in association to atypical antipsychotics in a sample of first-episode patients with schizophrenia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0087997
  contributor:
    fullname: Rizos
– volume: 2975
  start-page: 1
  year: 2018
  ident: 10.1016/j.jpsychires.2018.09.007_bib67
  article-title: The role of the gut microbiota in schizophrenia: current and future perspectives
  publication-title: World J. Biol. Psychiatr.
  doi: 10.1080/15622975.2018.1433878
  contributor:
    fullname: Rodrigues-Amorim
– year: 2005
  ident: 10.1016/j.jpsychires.2018.09.007_bib69
  article-title: The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia
  publication-title: Eur. Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2004.12.005
  contributor:
    fullname: Shoval
– volume: 141
  start-page: 513
  year: 2006
  ident: 10.1016/j.jpsychires.2018.09.007_bib1
  article-title: BDNF gene variants and brain morphology in schizophrenia
  publication-title: Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
  doi: 10.1002/ajmg.b.30338
  contributor:
    fullname: Agartz
– year: 2000
  ident: 10.1016/j.jpsychires.2018.09.007_bib34
  article-title: Neurotrophin signal transduction in the nervous system
  publication-title: Curr. Opin. Neurobiol.
  doi: 10.1016/S0959-4388(00)00092-1
  contributor:
    fullname: Kaplan
– volume: 14
  start-page: 617
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib75
  article-title: Functional switch from pro-neurotrophins to mature neurotrophins
  publication-title: Curr. Protein Pept. Sci.
  doi: 10.2174/1389203711209070658
  contributor:
    fullname: Sun
– volume: 131
  start-page: 1187
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib94
  article-title: Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls
  publication-title: Hum. Genet.
  doi: 10.1007/s00439-012-1150-x
  contributor:
    fullname: Zhang
– volume: 62
  start-page: e1
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib42
  article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
  publication-title: J. Clin. Epidemiol.
  doi: 10.1016/j.jclinepi.2009.06.006
  contributor:
    fullname: Liberati
– volume: 351
  start-page: 365
  year: 1996
  ident: 10.1016/j.jpsychires.2018.09.007_bib43
  article-title: Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview
  publication-title: Philos. Trans. R. Soc. B Biol. Sci.
  doi: 10.1098/rstb.1996.0030
  contributor:
    fullname: Lindsay
– volume: 119
  start-page: 47
  year: 2010
  ident: 10.1016/j.jpsychires.2018.09.007_bib32
  article-title: Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2009.12.035
  contributor:
    fullname: Jindal
– volume: 11
  start-page: 251
  year: 2010
  ident: 10.1016/j.jpsychires.2018.09.007_bib63
  article-title: Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics
  publication-title: World J. Biol. Psychiatr.
  doi: 10.3109/15622970802182733
  contributor:
    fullname: Rizos
– volume: 60
  start-page: 117
  year: 2003
  ident: 10.1016/j.jpsychires.2018.09.007_bib54
  article-title: Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome
  publication-title: Schizophr. Res.
  doi: 10.1016/S0920-9964(02)00434-6
  contributor:
    fullname: Parikh
– volume: 80
  start-page: 36
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib2
  article-title: Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment
  publication-title: Scand. J. Immunol.
  doi: 10.1111/sji.12158
  contributor:
    fullname: Ajami
– volume: 28
  start-page: 709
  year: 2004
  ident: 10.1016/j.jpsychires.2018.09.007_bib57
  article-title: Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2004.05.008
  contributor:
    fullname: Pirildar
– volume: 93
  start-page: 37
  year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib66
  article-title: Schizophrenia: a review of potential biomarkers
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2017.05.009
  contributor:
    fullname: Rodrigues-Amorim
– volume: 335
  start-page: 914
  year: 2007
  ident: 10.1016/j.jpsychires.2018.09.007_bib30
  article-title: Uncertainty in heterogeneity estimates in meta-analyses
  publication-title: BMJ
  doi: 10.1136/bmj.39343.408449.80
  contributor:
    fullname: Ioannidis
– start-page: 73
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib25
  article-title: Tissue engineering in peripheral nerve regeneration
  contributor:
    fullname: Gu
– volume: 40
  start-page: 664
  year: 2006
  ident: 10.1016/j.jpsychires.2018.09.007_bib27
  article-title: Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2005.11.004
  contributor:
    fullname: Huang
– volume: 575
  start-page: 37
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib53
  article-title: Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2014.05.034
  contributor:
    fullname: Niitsu
– volume: 74
  start-page: 263
  year: 2005
  ident: 10.1016/j.jpsychires.2018.09.007_bib79
  article-title: Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2004.08.004
  contributor:
    fullname: Tan
– year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib9
  article-title: Genetic insights into the neurodevelopmental origins of schizophrenia
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn.2017.125
  contributor:
    fullname: Birnbaum
– volume: 92
  start-page: 305
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib74
  article-title: BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism
  publication-title: Life Sci.
  doi: 10.1016/j.lfs.2013.01.008
  contributor:
    fullname: Sotiropoulou
– volume: 66
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib83
  article-title: Is serum brain-derived neurotrophic factor (BDNF) a biomarker for cognitive enhancement in schizophrenia?
  publication-title: Biol. Psychiatr.
  doi: 10.1016/j.biopsych.2009.02.017
  contributor:
    fullname: Vinogradov
– volume: 204
  start-page: 636
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib39
  article-title: Levels of serum brain-derived neurotrophic factor in schizophrenia
  publication-title: J. Nerv. Ment. Dis.
  doi: 10.1097/NMD.0000000000000463
  contributor:
    fullname: Lee
– volume: 4
  start-page: 1
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib50
  article-title: BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory
  publication-title: Front. Psychiatr.
  doi: 10.3389/fpsyt.2013.00045
  contributor:
    fullname: Nieto
– volume: 12
  year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib6
  article-title: Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0189373
  contributor:
    fullname: Bakirhan
– volume: 222
  start-page: 277
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib97
  article-title: Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
  publication-title: Psychopharmacology (Berlin)
  doi: 10.1007/s00213-012-2643-y
  contributor:
    fullname: Zhang
– volume: 45
  start-page: 273
  year: 2011
  ident: 10.1016/j.jpsychires.2018.09.007_bib11
  article-title: Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2010.06.012
  contributor:
    fullname: Carlino
– volume: 47
  start-page: 1052
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib93
  article-title: Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes
  publication-title: Clin. Biochem.
  doi: 10.1016/j.clinbiochem.2014.03.021
  contributor:
    fullname: Zakharyan
– volume: 207
  start-page: 375
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib12
  article-title: Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes
  publication-title: Psychopharmacology (Berlin)
  doi: 10.1007/s00213-009-1665-6
  contributor:
    fullname: Chen
– volume: 234
  start-page: 84
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib100
  article-title: Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls
  publication-title: Psychiatry Res. Neuroimaging.
  doi: 10.1016/j.pscychresns.2015.08.009
  contributor:
    fullname: Zugman
– volume: 327
  start-page: 557
  year: 2003
  ident: 10.1016/j.jpsychires.2018.09.007_bib26
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ Br. Med. J. (Clin. Res. Ed.)
  doi: 10.1136/bmj.327.7414.557
  contributor:
    fullname: Higgins
– volume: 39
  start-page: 130
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib84
  article-title: Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia
  publication-title: Schizophr. Bull.
  doi: 10.1093/schbul/sbr070
  contributor:
    fullname: Wong
– volume: 35
  start-page: 1836
  year: 2011
  ident: 10.1016/j.jpsychires.2018.09.007_bib52
  article-title: Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2011.09.004
  contributor:
    fullname: Niitsu
– volume: 62
  start-page: 87
  year: 2010
  ident: 10.1016/j.jpsychires.2018.09.007_bib62
  article-title: Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia
  publication-title: Neuropsychobiology
  doi: 10.1159/000315438
  contributor:
    fullname: Rizos
– volume: 45
  start-page: 841
  year: 2015
  ident: 10.1016/j.jpsychires.2018.09.007_bib71
  article-title: Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
  publication-title: Psychol. Med.
  doi: 10.1017/S0033291714001925
  contributor:
    fullname: Skilleter
– volume: 244
  start-page: 370
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib76
  article-title: Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture
  publication-title: Psychiatr. Res.
  doi: 10.1016/j.psychres.2016.07.040
  contributor:
    fullname: Sun
– volume: 61
  start-page: 911
  year: 2007
  ident: 10.1016/j.jpsychires.2018.09.007_bib22
  article-title: Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia
  publication-title: Biol. Psychiatr.
  doi: 10.1016/j.biopsych.2006.08.025
  contributor:
    fullname: Gratacòs
– volume: 86
  start-page: 39
  year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib60
  article-title: Peripheral blood nerve growth factor levels in major psychiatric disorders
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2016.11.012
  contributor:
    fullname: Rao
– volume: 2
  start-page: 339
  year: 2000
  ident: 10.1016/j.jpsychires.2018.09.007_bib78
  article-title: The biology of schizophrenia
  publication-title: Dialogues Clin. Neurosci.
  doi: 10.31887/DCNS.2000.2.4/ctamminga
  contributor:
    fullname: Tamminga
– volume: 209
  start-page: 150
  year: 2013
  ident: 10.1016/j.jpsychires.2018.09.007_bib36
  article-title: Lifestyle modification and behavior therapy effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese non-diabetic patients with schizophrenia
  publication-title: Psychiatr. Res.
  doi: 10.1016/j.psychres.2012.11.020
  contributor:
    fullname: Kuo
– volume: 41
  start-page: 997
  year: 2007
  ident: 10.1016/j.jpsychires.2018.09.007_bib99
  article-title: Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2006.08.007
  contributor:
    fullname: Zhang
– volume: 42
  start-page: 142
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib45
  article-title: BDNF and NGF signalling in early phases of psychosis: relationship with inflammation and response to antipsychotics after 1 year
  publication-title: Schizophr. Bull.
  contributor:
    fullname: Martinez-Cengotitabengoa
– volume: 33
  start-page: 1508
  year: 2009
  ident: 10.1016/j.jpsychires.2018.09.007_bib89
  article-title: Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2009.08.011
  contributor:
    fullname: Xiu
– start-page: 9
  year: 1994
  ident: 10.1016/j.jpsychires.2018.09.007_bib77
  article-title: Biological factors in schizophrenia. Structural and functional aspects
  publication-title: Br. J. Psychiatr. Suppl.
  doi: 10.1192/S0007125000292672
  contributor:
    fullname: Syvälahti
– volume: 51
  start-page: 169
  year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib98
  article-title: Interaction of BDNF with cytokines in chronic schizophrenia
  publication-title: Brain Behav. Immun.
  doi: 10.1016/j.bbi.2015.09.014
  contributor:
    fullname: Zhang
– volume: 220
  start-page: 792
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib35
  article-title: Increase of circulating BDNF levels and its relation to improvement of physical fitness following 12 weeks of combined exercise in chronic patients with schizophrenia: a pilot study
  publication-title: Psychiatr. Res.
  doi: 10.1016/j.psychres.2014.09.020
  contributor:
    fullname: Kim
– volume: 48
  start-page: 136
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib96
  article-title: Gender difference in association of cognition with BDNF in chronic schizophrenia
  publication-title: Psychoneuroendocrinology
  doi: 10.1016/j.psyneuen.2014.06.004
  contributor:
    fullname: Zhang
– year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib55
  article-title: Theranostic biomarkers for schizophrenia
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms18040733
  contributor:
    fullname: Perkovic
– volume: 75
  start-page: e794
  year: 2014
  ident: 10.1016/j.jpsychires.2018.09.007_bib87
  article-title: Combining serum protein concentrations to diagnose schizophrenia: a preliminary exploration
  publication-title: J. Clin. Psychiatr.
  doi: 10.4088/JCP.13m08772
  contributor:
    fullname: Xiong
– volume: 27
  start-page: 33
  year: 2012
  ident: 10.1016/j.jpsychires.2018.09.007_bib91
  article-title: Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients
  publication-title: Hum. Psychopharmacol. Clin. Exp.
  doi: 10.1002/hup.1257
  contributor:
    fullname: Yoshimura
– year: 2016
  ident: 10.1016/j.jpsychires.2018.09.007_bib14
  article-title: Schizophrenia: from genetics to physiology at last
  publication-title: Nature
  doi: 10.1038/nature16874
  contributor:
    fullname: Dhindsa
– volume: 39
  start-page: 327
  year: 2010
  ident: 10.1016/j.jpsychires.2018.09.007_bib31
  article-title: An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2010.04.017
  contributor:
    fullname: Issa
– volume: 7
  start-page: e1075
  year: 2017
  ident: 10.1016/j.jpsychires.2018.09.007_bib82
  article-title: Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies
  publication-title: Transl. Psychiatry
  doi: 10.1038/tp.2017.4
  contributor:
    fullname: van Kesteren
– volume: 40
  start-page: 664
  year: 2006
  ident: 10.1016/j.jpsychires.2018.09.007_bib28
  article-title: Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients
  publication-title: J. Psychiatr. Res.
  doi: 10.1016/j.jpsychires.2005.11.004
  contributor:
    fullname: Huang
– volume: 31
  start-page: 1072
  year: 2007
  ident: 10.1016/j.jpsychires.2018.09.007_bib92
  article-title: Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients
  publication-title: Prog. Neuro Psychopharmacol. Biol. Psychiatr.
  doi: 10.1016/j.pnpbp.2007.03.010
  contributor:
    fullname: Yoshimura
SSID ssj0007214
Score 2.4831
Snippet Schizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological interactions known...
BACKGROUNDSchizophrenia is associated with patterns of aberrant neurobiological circuitry. The disease complexity is mirrored by multiple biological...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 43
Title The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis
URI https://dx.doi.org/10.1016/j.jpsychires.2018.09.007
https://www.ncbi.nlm.nih.gov/pubmed/30269004
https://search.proquest.com/docview/2115274811
Volume 106
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF6KgngR39YXK3iNZptNstFTEaUq7UnB25Lsg0YwKW168OJvdyabtAoKgsdkNyTMbOax-803hJxnYcp8E1ovEMJ4PNaBl6U683gG7j1NUghRMVEcjqLBM394CV865KathUFYZWP7nU2vrXVz57KR5uUkz7HGF1wb1mWKAPvSIScokm3Bmr74WMI8IMPhC8ZwmN2geRzG69VBiiGxRZCXqBlPsbHszy7qtxC0dkV3m2SjiSFp333mFumYYpusDZtT8h0yBt3TmqjSUSyhHuj4fYLFVrN8RkvrRqtpORnnxYzmBYUhit2Jy3qro95rx3mzr5i8K9qnb6ZKvbRhMtklz3e3TzcDr-mo4CkehZVnI5EIm4S-CnpWMT_zewlPwEnFEOhYnsVRyjRELGEv1hBZKMMD5fuGMQV5nw51sEdWirIwByBEFWuB2WFPKW4jKwSktNo3lhsdMx52CWuFKCeOOEO2iLJXuRS8RMFLP5Eg-C65bqUtvy0CCfb9D0-ftQqS8I_gwUdamHIOkxg27-WCsS7Zd5pbfFMASWgCluLwX-8-Iut45YoUj8lKNZ2bE4hWquy0Xo6nZLV__zgYfQIv7euQ
link.rule.ids 315,783,787,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA66gnoR367PCF6rzTZtUz2JuKyP9aTgLbR5sF2wXdx68OJvd6ZpfYCC4LVJaZhJZ-ZLvpkh5CgLU-ab0HqBEMbjsQ68LNWZxzNw72mSQoiKQHF4Fw0e-PVj-DhDLtpcGKRVNrbf2fTaWjdPThppnkzyHHN8wbVhXqYIsC8dnyVzHOtnwaY-fvvkeQDE4R8lw2F6Q-dxJK-x4xQDskWWl6hLnmJn2Z991G8xaO2L-stkqQki6blb5wqZMcUqmR821-RrZATKp3WlSldjCRVBR68TzLaa5lNaWjdaPZeTUV5MaV5QGKLYnriszzrqw3acN_1Kyjul5_TJVKmXNqVM1slD__L-YuA1LRU8xaOw8mwkEmGT0FdBzyrmZ34v4Ql4qRgiHcuzOEqZhpAl7MUaQgtleKB83zCmAPjpUAcbpFOUhdkCIapYC4SHPaW4jawQgGm1byw3OmY87BLWClFOXOUM2VLKxvJT8BIFL_1EguC75KyVtvy2CyQY-D-8fdgqSMJPgjcfaWHKF5jEsHsvF4x1yabT3MeaAkChCZiK7X99-4AsDO6Ht_L26u5mhyziiMtY3CWd6vnF7EHoUmX79dZ8B9Bh7TI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+neurobiological+hypothesis+of+neurotrophins+in+the+pathophysiology+of+schizophrenia%3A+A+meta-analysis&rft.jtitle=Journal+of+psychiatric+research&rft.au=Rodrigues-Amorim%2C+Daniela&rft.au=Rivera-Baltan%C3%A1s%2C+Tania&rft.au=Bessa%2C+Jo%C3%A3o&rft.au=Sousa%2C+Nuno&rft.date=2018-11-01&rft.pub=Elsevier+Ltd&rft.issn=0022-3956&rft.eissn=1879-1379&rft.volume=106&rft.spage=43&rft.epage=53&rft_id=info:doi/10.1016%2Fj.jpsychires.2018.09.007&rft.externalDocID=S0022395618305934
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3956&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3956&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3956&client=summon